Summary
This prediction ended on 09.09.13 with a price of €83.46. The BUY prediction by DirectorDealer_Intensive finished with a performance of 9.02%. DirectorDealer_Intensive has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -3.868% | -3.868% | 80.101% | -9.113% |
| iShares Core DAX® | 0,44 % | 5,64 % | 7,81 % | 63,64 % |
| iShares Nasdaq 100 | 1,06 % | 0,28 % | 27,24 % | 88,12 % |
| iShares Nikkei 225® | 1,77 % | 0,41 % | 49,27 % | 83,53 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 22,34 % | 68,75 % |
Comments by DirectorDealer_Intensive for this prediction
In the thread Bayer AG diskutieren
Director Dealing: Kauf
Director Dealing / Insider Kauf von Börsig, Dr. Clemens (Aufsichtsorgan)
- Handelstag: 05.03.13
- Volumen: 20324 €
- Meldender: Börsig, Dr. Clemens
Wir werten alle Insider Käufe aus. Gemeinsam mit der Universität Innsbruck wurde eine Handelsstrategie auf Basis des Intensive Tradings entwickelt. Mehr Informationen finden Sie im Profil von DirectorDealer_Intensive
.
Director Dealing / Insider Kauf von Schmidt-Kiessling, Michael (Aufsichtsorgan)
- Handelstag: 06.03.13
- Volumen: 20324 €
- Meldender: Schmidt-Kiessling, Michael
(Laufzeit überschritten)